DiaMedica Therapeutics Inc. (DMAC) has a market capitalization of $352.39M and trades at $6.54. The 52-week range is 3.19-10.4195.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.3, Earnings Per Share (EPS) of $-0.70.
The stock has a beta of 1.15, operates in the Healthcare sector.
